Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase

Nature

Volumn 400, Issue 6742, 1999, Pages 378-382

  Huang, Jannet T ^a   Welch, John S ^a   Ricote, Mercedes ^a   Binder, Christoph J ^a   Willson, Timothy M ^c   Kelly, Carolyn ^a   Witztum, Joseph L ^a   Funk, Colin D ^d   Conrad, Douglas ^b   Glass, Christopher K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; CORIOLIC ACID; INTERLEUKIN 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYUNSATURATED FATTY ACID;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, CD36; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-4; LIGANDS; MACROPHAGES; MICE; MICE, KNOCKOUT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0033595261     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/22572     Document Type: Article

References (30)

1. Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 1147-1156 (1994).
2. Lehmann, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor-γ (PPAR-γ). J. Biol. Chem. 270, 12953-12956 (1995).
3. Willson, T. M. et al. The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 39, 665-668 (1996).
4. Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A. & Evans, R. M. PPARγ promotes monocyte/ macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252 (1998).
5. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. & Glass, C. K. The peroxisome proliferator-activattd receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82 (1998).
6. Jiang, C., Ting, A. T. & Seed, B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86 (1998).
7. Kliewer, S. A. et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl Acad. Sci. USA 94, 4318-4323 (1997).
8. 2 metabolite binds peroxisome prolifator-activated receptorγ and promotes adipocyte differentiation. Cell 83, 813-819 (1995).
9. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812 (1995).
10. Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H. & Evans, R. M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR-γ. Cell 93, 229-240 (1998).
11. Conrad, D. J., Kuhn, H., Mulkins, M., Highland, E. & Sigal, E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc. Natl Acad. Sci. USA 89, 217-221 (1992).
12. Ricote, M. et al. Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc. Natl Acad. Sci. USA 95, 7614-7619 (1998).
13. Zhu, Y. et al. Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPAR γ) gene: alternative promoter use and different splicing yield two mPPAR γ isoforms. Proc. Natl Acad. Sci. USA 92, 7921-7925 (1995).
14. Fajas, L., Fruchart, J. C. & Auwerx, J. PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter. FEBS Lett. 438, 55-60 (1998).
15. Yamamoto, S. Mammalian lipoxygenases: molecular structure and functions. Biochem. Biophys. Res. Commun. 1128, 117-131 (1992).
16. van Leyen, K., Duvoisin, R. M., Engelhardt, H. & Wiedmann, M. A function for lipoxygenase in programmed organelle degradation. Nature 395, 392-395 (1998).
17. Rankin, S. M., Parthasarathy, S. & Steinberg, D. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J. Lipid Res. 32, 449-456 (1991).
18. Benz, D. J. et al. Enhanced levels of lipoperoxides in low density lipoproteins incubated with murine fiproblasts expressing high levels of human 15-lipoxygenase. J. Biol. Chem. 270, 5191-5197 (1995).
19. Funk, C. D. The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim. Biophys. Acta 1304, 65-84 (1996).
20. Kuhn, H. Biosynthesis, metabolization and biological importance of the primary 15-lipoxygenase metabolites 15-hydro(pero)xy-5Z,8Z,11Z,13E-eicosatetraenoic acid and 13-hydro(pero)xy-9Z,11E-octadecadienoic acid. Prog. Lipid Res. 35, 203-226 (1996).
21. Heydeck, D. et al. Interleukin-4 and -13 induce upregulation of the murine macrophage 12/15-lipoxygenase activity: evidence for the involvement of transcription factor STAT6. Blood 92, 2503-2510 (1998).
22. Scheidegger, K. J., Butler, S. & Witztum, J. L. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway. J. Biol. Chem. 272, 21609-21615 (1997).
23. Bogdan, C., Vodovotz, Y., Paik, J., Xie, Q.-W. & Nathan, C. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leukocyte Biol. 55, 227-233 (1994).
24. Yesner, L. M., Huh, H. Y., Pearce, S. F. & Silverstan, R. L. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler. Thromb. Vasc. Biol. 16, 1019-1025 (1996).
25. Yamada, Y., Doi, T., Hamakubo, T. & Kodama, T. Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system. Cell. Mol. Life Sci. 54, 628-640 (1998).
26. Endemann, G. et al. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268, 11811-11816 (1993).
27. Savill, J. S., Hogg, N., Ren, Y. & Haslett, C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90, 1513-1522 (1992).
28. Sun, D. & Funk, C. D. Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. J. Biol. Chem. 271, 24055-24062 (1996).
29. Nolte, R. T. et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395, 137-143 (1998).
30. Sigal, E. C., Craik, C. S. & Highland, E. Molecular cloning and primary structure of human 15-lipoxygenase. Biochem. Biophys. Res. Commun. 157, 457-464 (1988).